Herein, we have developed a new approach
for the synthesis of 11
to 21-membered macrolactones via intramolecular dehydrogenative coupling
of primary alcohols by using Ru-MACHO as a catalyst and Cs2CO3 as a base. This protocol generated 11–21-ring-sized macrocycles (26 derivatives),
free from an external oxidant or an additive, eliminating stoichiometric
reagents and producing only hydrogen as a byproduct.
Herein
we describe a new approach for end-to-end cyclization to
construct macrocycles through the inter/intramolecular dehydrogenative
coupling of alcohols and ketones in the presence of a Ru-MACHO catalyst.
This method is highly atom economical and sustainable and can be used
for many substrates. Additionally, this method results in the generation
of only water as the byproduct. Moreover, in this approach, high dilution
of the reactants is crucial for cyclization and high-yield macrocycle
synthesis.
An efficient continuous flow process
for the macrolactonization
of seco acids and diacids using diols in the presence of Mukaiyama
reagent (N-methyl-2-chloropyridinium iodide) has
been developed for medium to large sized macrocyclic lactones. In
comparison with other methods, the continuous flow process provided
good to high yield in a short reaction time. By using this methodology,
a wide range of macrocyclic lactones (11 compounds), dilactones (15
compounds), and tetralactone derivatives (2 compounds) with various
ring sizes (12–26 atoms in the core) were synthesized in just
35 min of residence time. Advantageously, macrolactonization under
the flow process is very elegant to handle the high dilution of reactants
with a defined perfluoroalkoxy alkanes (PFA) tube reactor volume (7
mL).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.